Understanding the association between narcolepsy and one of the 2009 adjuvanted influenza A (H1N1) vaccines
This meeting was designed to offer a place to exchange the latest information on into the development of narcolepsy following vaccination with one of the 2009 adjuvanted influenza A(H1N1) vaccines.
Assessment of human influenza pandemic scenarios in Europe
Napoli, C., Fabiani, M., Rizzo, C., Barral, M., Oxford, J., Cohen, J.M., Niddam, L., Goryński, P., Pistol, A., Lionis, C., Bri, S., Nicoll, A., Penttinen, P., Gauci, C., Bounekkar, A., Bonnevay, S., Beresniak, A.
Influenza virus characterisation, July 2014
During the 2013–14 season, A(H1N1)pdm09, A(H3N2), B/Victoria- and B/Yamagata-lineage influenza viruses have continued to co-circulate in EU/EEA Member States.
Risk assessment guidelines for infectious diseases transmitted on aircraft (RAGIDA): Influenza
This report which is part of the RAGIDA project (Risk Assessment Guidance for Infectious Diseases transmitted on Aircraft) provides viable options for decision-makers when faced with the choice of whether to contact trace air travellers and crew that were potentially exposed to infectious diseases during a flight.
- Avian influenza virus
- Infectious diseases on aircrafts
- Influenza A (H1N1)2009
- Influenza A(H5N1) virus
- Influenza A(H5N2) virus
- Influenza A(H5N8) virus
- Influenza A(H7N9) virus
- Influenza in humans, avian origin
- Influenza in humans, pandemic
- Influenza in humans, seasonal
- Influenza in humans, swine origin
- Risk assessment guidelines for infectious diseases transmitted on aircraft (RAGIDA)
- Travellers' health
Weekly influenza surveillance overview, Nov 15, 2013 - week 45
During week 45/2013: All 27 reporting countries experienced low intensity influenza activity.